Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Alanine, Arginine, Aspartic acid, Glutamic acid, Glycine, Histidine, Isoleucine, Leucine, Lysine acetate, Lysine monohydrate, Methionine, Phenylalanine, Proline, Serine, Threonine, Tryptophan, Tyrosine, Valine may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
for
Aminoplasmal 10% is a solution which is given to you through a small tube with a cannula placed in a vein (intravenous infusion). The solution contains amino acids that are essential for the body to grow or to recover. You will receive this medicine if you are unable to eat food normally and you cannot be fed through a tube placed into your stomach either. This solution can be given to adults, adolescents and children over 2 years of age.
2.
e Aminoplasmal 10%
Do not use Aminoplasmal 10% ● if you are allergic to any of the active substances or any of the other ingredients of this medicine (listed in section 6) ● if you suffer from an inborn error of your metabolism of proteins and amino acids ● if you have a severe (i.e. life-threatening) circulation disorder (shock) ● if you have insufficient oxygen supply (hypoxia) ● if acidic substances accumulate in your blood (metabolic acidosis) ● if you have a severe liver disease (severe hepatic insufficiency or decompensated liver cirrhosis with hepatic encephalopathy grades III and IV) ● if you have severe kidney failure (severe renal insufficiency) not adequately treated by artificial kidney or similar therapies ● if you suffer from a poorly controlled heart failure with marked impairment of your blood circulation (decompensated cardiac insufficiency) ● if you have accumulation of fluid in your lungs (acute pulmonary oedema) ● if your body's salt (electrolyte) or water balance is disturbed
04511.0MS0120B15
This solution must not be given to newborn babies, infants and toddlers less than two years of age because the composition of the solution does not properly meet the special nutrition requirements of this age group. Warnings and precautions Talk to your doctor or pharmacist before using Aminoplasmal 10% ● if you suffer from an impairment of your metabolism of proteins and amino acids caused by any condition other than mentioned above (see section "Do not use …") ● if you have mild to moderate impairment of your liver or decompensated liver cirrhosis with hepatic encephalopathy (grades I and II) or kidney function ● if you have an impairment of your heart function ● if you have abnormally high concentrated blood serum (high serum osmolarity) If your body's water or salt balance is disturbed, this condition should be corrected before you receive this medicine. Examples for this condition are a lack of water and salts at the same time (hypotonic dehydration) or a lack of sodium (hyponatraemia) or potassium (hypokalaemia). Before and while you are receiving this medicine, your blood salt levels, blood sugar levels, the water balance, the acid-base balance, your blood proteins and kidney and liver function will be monitored. For this purpose blood samples will be taken and your urine will be collected and both will be analysed. Usually you will receive Aminoplasmal 10% as part of intravenous feeding which also includes non-protein energy supplements (carbohydrate solutions, fat emulsions), essential fatty acids, electrolytes, vitamins, fluids and trace elements. Other medicines and Aminoplasmal 10% Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Pregnancy If you are pregnant, you will receive this medicine only if the doctor considers it necessary for your recovery. There are no data available about the use of this medicine in pregnant women. Breast-feeding At therapeutic doses of Aminoplasmal 10% no effects on the breastfed newborn/infant are anticipated. Nevertheless, breast-feeding is not recommended if women need intravenous feeding at the same time.
Driving and using machines This medicine is normally given to immobile patients in a controlled setting (emergency treatment, acute treatment in a hospital or a day therapy unit). This will exclude driving and using machines.
04511.0MS0120B15
3.
Aminoplasmal 10%
Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. Dosage Adults Your doctor will determine the amount of solution you need each day. In general, this will be 10 – 20 ml per kg of your body weight per day. The solution will flow in at a rate of not more than 1 ml per kg of your body weight per hour. Children from 2 to 18 years old In children the doctor will adjust the dosage carefully according to the individual child's age, status of development and actual disease. The amounts to be given will be: 2 to less than 3 years old: 10 – 25 ml per kg of body weight per day 3 to 18 years old: 10 – 20 ml per kg of body weight per day For critically ill children the amount to be given may be higher (up to 30 ml per kg body weight per day). The solution will run in at a rate of not more than 1 ml per kg body weight per hour. Patients with kidney or liver disease The doses will be adjusted according to your individual requirements if you have liver (mild to moderate hepatic insufficiency or decompensated liver cirrhosis with hepatic encephalopathy grades I and II) or kidney disease. When given during dialysis amino acid losses into the dialysate have to be considered. Duration of use This medicine may be used as long as you need intravenous feeding. Method of administration This medicine will be administered to you through a small tube inserted into one of your large veins (central venous infusion). If you received more Aminoplasmal 10% than you should It is unlikely that this occurs because your doctor will determine your daily doses. However, if you receive an overdose or the solution is flowing too fast, you may feel sick, may have to vomit and/or have a headache. Also, your blood may contain too much ammonia (hyperammonaemia) and you may lose amino acids in the urine. You may also suffer from too much fluid in your body (hyperhydration), your body's salt balance may be disturbed (electrolyte imbalance) and you may have water on your lungs (pulmonary oedema). If this happens, the infusion will be stopped and started again at a lower infusion rate some time later. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Such side effects are not specifically related to Aminoplasmal 10% but may occur with any kind of intravenous feeding, especially at the beginning.
04511.0MS0120B15
The following side effects may be serious. If any of the following side effects occur, tell your doctor immediately, he will stop giving you this medicine: Not known (frequency cannot be estimated from the available data) ● Allergic reactions
Other side effects Uncommon (may affect up to 1 in 100 people) ● Vomiting, feeling sick Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
5.
Aminoplasmal 10%
Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the bottle and carton labels. The expiry date refers to the last day of that month. Keep the bottle in the outer carton in order to protect from light. Do not store above 25 C. Cool storage of the solution, below 15 °C, may lead to formation of crystals, that can, however, be easily dissolved by gentle warming at 25 °C until dissolution is complete. Shake container gently to ensure homogeneity. Do not freeze. After infusion, any remaining solution should never be stored for later use.
6.
What Aminoplasmal 10 % contains The active substances are amino acids.
04511.0MS0120B15
This medicine contains:
Isoleucine Leucine Lysine monohydrate (equivalent to lysine) Lysine acetate (equivalent to lysine) Methionine Phenylalanine Threonine Tryptophan Valine Arginine Histidine Alanine Glycine Aspartic acid Glutamic acid Proline Serine Tyrosine
per 1 ml per 250 ml per 500 ml per 1000 ml 5.00 mg 1.25 g 2.50 g 5.00 g 8.90 mg 2.23 g 4.45 g 8.90 g 3.12 mg 3.12 g 0.78 g 1.56 g (2.78 mg) (2.78 g) (0.70 g) (1.39 g) 5.74 mg 5.74 g 1.44 g 2.87 g (4.07 mg) (4.07 g) (1.02 g) (2.04 g) 4.40 mg 1.10 g 2.20 g 4.40 g 4.70 mg 1.18 g 2.35 g 4.70 g 4.20 mg 1.05 g 2.10 g 4.20 g 1.60 mg 0.40 g 0.80 g 1.60 g 6.20 mg 1.55 g 3.10 g 6.20 g 11.50 mg 2.88 g 5.75 g 11.50 g 3.00 mg 0.75 g 1.50 g 3.00 g 10.50 mg 2.63 g 5.25 g 10.50 g 12.00 mg 3.00 g 6.00 g 12.00 g 5.60 mg 1.40 g 2.80 g 5.60 g 7.20 mg 1.80 g 3.60 g 7.20 g 5.50 mg 1.38 g 2.75 g 5.50 g 2.30 mg 0.58 g 1.15 g 2.30 g 0.40 mg 0.10 g 0.20 g 0.40 g
The other ingredients are acetylcysteine, citric acid monohydrate (for pH-adjustment) and water for injections. Electrolyte concentrations Acetate Citrate Total amino acids Total nitrogen Energy [kJ/l (kcal/l)] Theoretical osmolarity [mOsm/l] Acidity (titration to pH 7.4) [mmol NaOH/l] pH
28 mmol/l 1.0 – 2.0 mmol/l 100 g/l 15.8 g/l 1675 (400) 864 approx. 20 5.7 – 6.3
What Aminoplasmal 10% looks like and contents of the pack Aminoplasmal 10% is a clear, colourless up to faintly straw-coloured solution, practically free from visible particles. The product comes in colourless glass bottles of 250 ml, 500 ml and 1000 ml, which are each closed by rubber stoppers. The 250 ml and 500 ml bottles are available in packs of 10. The 1000 ml bottles are available in packs of 6. Not all pack sizes may be marketed.
04511.0MS0120B15
Marketing Authorisation Holder and Manufacturer B. Braun Melsungen AG Carl-Braun-Straße 1 34212 Melsungen Germany Postal address 34209 Melsungen, Germany Phone: +49-5661-71-0 Fax: +49-5661-71-4567 This medicine is authorised in the Member States of the European Economics Area and in the United Kingdom (GB and NI) under the following names: Austria, Germany Czech Republic, Poland, Portugal, Slovakia Denmark Spain Finland Italy Lithuania Latvia Netherlands Slovenia United Kingdom (GB and NI)
Aminoplasmal B. Braun 10 % Infusionslösung Aminoplasmal B. Braun 10 % Aminoplasmal Aminoplasmal B. Braun 10 % solución para perfusión Aminoplasmal 16 N/l infuusioneste, liuos Amixal Aminoplasmal B. Braun 10 % infuzinis tirpalas Aminoplasmal B. Braun 10 % šķīdums infūzijām Aminoplasmal B. Braun 10 % E-vrij, oplossing voor infusie Amixal 100 mg/ml raztopina za infundiranje Aminoplasmal 10 % solution for infusion
This leaflet was last revised in May 2025 ———————————————————————————————————————————–The following information is intended for healthcare professionals only: Dosage In the case of amino acid requirements of 1.0 g per kg body weight per day or more, particular attention should be paid to the limitations of fluid input. To avoid fluid overload, amino acid solutions with higher amino acid content may have to be used in such situations. Patients with renal/hepatic impairment The doses should be adjusted individually in patients with mild to moderate hepatic or decompensated liver cirrhosis with hepatic encephalopathy (grades I and II) or renal insufficiency. When given during dialysis amino acid losses into the dialysate have to be considered. Instructions for handling Use a sterile giving set for infusion of Aminoplasmal 10%. If in the setting of complete parenteral nutrition it is necessary to add other nutrients such as carbohydrates, lipids, vitamins, electrolytes and trace elements to this medicinal product, admixing must be performed under strict aseptic conditions. Mix well after admixture of any additive. Aminoplasmal 10% can only be mixed
04511.0MS0120B15
with other nutrients for which compatibility has been documented. Compatibility data for different additives and the corresponding shelf life of such admixtures can be provided on demand by the manufacturer. Pay special attention to compatibility. –
–
Glucose: physicochemical stability has been demonstrated for 24 hours at room temperature up to a total quantity of 158 g/l of glucose in the mixture. Electrolytes: physicochemical stability has been demonstrated for 24 hours at room temperature up to a total quantity of 32 mmol/l of sodium, 16 mmol/l potassium and 2 mmol/l of magnesium in the mixture. Lipids: physicochemical stability has been demonstrated for 24 hours at room temperature up to a total quantity of 50 g/l of lipid emulsion in the mixture. Trace elements and vitamins: stability has been demonstrated for 24 hours at room temperature with commercially available multi-trace elements and multi-vitamins (e.g. Tracutil, Cernevit) up to the standard dosage recommended by the respective manufacturer of the micronutrient.
Special precaution for storage The solution should only be used if the closure of the container is not damaged and if the solution is clear colourless to faintly straw-coloured, practically free from visible particles. Containers are for single use only. Discard container and any unused contents after use. Shelf life after admixture of additives Do not refrigerate. Chemical and physical in-use stability has been demonstrated for 24 hours at 25 oC. From a microbiological point of view, unless the method of opening and mixing precludes the risk of microbial contamination, the product should be used immediately. If not used immediately, in-use storage times and conditions are the responsibility of the user. For complete information on this medicinal product please refer to the Summary of Product Characteristics.
04511.0MS0120B15
Aminoplasmal 10% Solution for Infusion comes as infusion. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Aminoplasmal 10% Solution for Infusion is alanine, arginine, aspartic acid, glutamic acid, glycine, histidine, isoleucine, leucine, lysine acetate, lysine monohydrate, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, valine.
This leaflet reproduces the patient information leaflet approved for Aminoplasmal 10% Solution for Infusion, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
Supply of amino acids for parenteral nutrition, when oral or enteral nutrition is impossible, insufficient or contraindicated. For adults, adolescents and children over 2 years of age.
Posology
The dosage has to be adjusted according to the individual need of amino acids and fluid depending on the clinical condition of the patient (nutritional status and/or degree of nitrogen catabolism due to underlying disease).
Adults
Daily dose:
1.0 – 2.0 g amino acids/kg body weight
≙ 10 – 20 ml/kg body weight
≙ 700 – 1400 ml for a 70 kg patient
Maximum infusion rate:
0.1 g amino acids/kg body weight/h
≙ 1.0 ml/kg body weight/h
≙ 1.17 ml/min for a 70 kg patient
Paediatric population
Newborn infants, infants and toddlers less than two years of age
Aminoplasmal 10% is contraindicated in newborn infants, infants and toddlers less than 2 years of age (see section 4.3).
Children and adolescents 2 to 18 years old
The dosages for the age groups stated below are average values for guidance. The exact dosage should be adjusted individually according to age, developmental stage and prevailing disease.
Daily dose for children 2 to less than 3 years old:
1.0 - 2.5 g amino acids/kg body weight ≙ 10 - 25 ml/kg body weight
Daily dose for children 3 to 18 years old:
1.0 - 2.0 g amino acids/kg body weight ≙ 10 - 20 ml/kg body weight
Critically ill children: For critically ill patients the advisable amino acid intake may be higher (up to 3.0 g amino acids/kg body weight per day).
Maximum infusion rate:
0.1 g amino acids/kg body weight/h ≙ 1.0 ml/kg body weight/h
In the case of amino acid requirements of 1.0 g/kg body weight/day or more, particular attention should be paid to the limitations of fluid input. To avoid fluid overload, amino acid solutions with higher amino acid content may have to be used in such situations.
Patients with renal/hepatic impairment
The doses should be adjusted individually in patients with mild and moderate hepatic or renal insufficiency (see also section 4.4). When given during dialysis amino acid losses into the dialysate have to be considered.
Duration of use
This solution can be administered as long as parenteral nutrition is indicated.
Method of administration
Intravenous use.
For central venous infusion only.
● Hypersensitivity to the active substances or to any of the excipients listed in section 6.1
● Inborn errors of amino acid metabolism
● Severe circulation disorders with vital risk (e.g. shock)
● Hypoxia
● Metabolic acidosis
● Severe hepatic insufficiency or decompensated liver cirrhosis with hepatic encephalopathy (grades III and IV)
● Severe renal insufficiency in absence of renal replacement therapy
● Decompensated cardiac insufficiency
● Acute pulmonary oedema
● Disturbances of the electrolyte and fluid balance
The medicinal product must not be administered to newborn infants, infants and toddlers less than two years of age, because the amino acid composition does not properly meet the special requirements of this paediatric age group.
The medicinal product should only be administered after careful benefit-risk assessment in the presence of disorders of amino acid metabolism of other origin than stated under section 4.3.
Care should be exercised in the administration of large volume infusion fluids to patients with cardiac insufficiency.
Caution should be exercised in patients with increased serum osmolarity.
Disturbances of fluid and electrolyte balance (e.g. hypotonic dehydration, hyponatraemia, hypokalaemia) should be corrected prior to the administration of parenteral nutrition.
Serum electrolytes, blood glucose, fluid balance, acid-base balance and renal function should be monitored regularly.
Monitoring should also include serum protein and liver function tests.
Renal impairment
In patients with renal insufficiency, the dose must be carefully adjusted according to individual needs, severity of organ insufficiency and the kind of instituted renal replacement therapy (haemodialysis, haemofiltration etc.). Amino acid losses due to the dialysis procedure had to be taken into consideration when adjusting the dose.
Hepatic impairment
In patients with mild and moderate hepatic insufficiency or decompensated liver cirrhosis with hepatic encephalopathy (grades I and II), the dose must be carefully adjusted according to individual needs and severity of organ insufficiency.
Amino acid solutions are only one component of parenteral nutrition. For complete parenteral nutrition, substrates for non-protein energy supply, essential fatty acids, electrolytes, vitamins, fluids and trace elements must be administered together with amino acids.
None known
Pregnancy
There are no data from the use of Aminoplasmal 10% in pregnant women. No animal reproductive studies have been performed with Aminoplasmal 10%. The use of Aminoplasmal 10% may be considered during pregnancy, if necessary. Aminoplasmal 10% should only be given to pregnant women after careful consideration.
Breast-feeding
Amino acids/metabolites are excreted in human milk, but at therapeutic doses of Aminoplasmal 10% no effects on the breastfed newborns/infants are anticipated.
Nevertheless, breast-feeding is not recommended for mothers on parenteral nutrition.
Fertility
No data available.
Not relevant.
Undesirable effects that, however, are not specifically related to the product but to parenteral nutrition in general may occur, especially at the beginning of parenteral nutrition.
Undesirable effects are listed according to their frequencies as follows:
Very common
Common
Uncommon
Rare
Very rare
Not known
(≥ 1/10)
(≥ 1/100 to < 1/10)
(≥ 1/1,000 to < 1/100)
(≥ 1/10,000 to < 1/1,000)
(< 1/10,000)
(cannot be estimated from the available data)
Immune system disorders
Not known: Allergic reactions
Gastrointestinal disorders
Uncommon: Nausea, vomiting
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellowcard scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Symptoms of fluid overdose
Overdose or too high infusion rates may lead to hyperhydration, electrolyte imbalance and pulmonary oedema.
Symptoms of amino acid overdose
Overdose or too high infusion rates may lead to intolerance reactions manifesting in the form of nausea, vomiting, headache, hyperammonaemia and renal amino acid losses.
Treatment
If intolerance reactions occur, the amino acid infusion must be interrupted temporarily and resumed later on at a lower infusion rate.
Ask anything about Aminoplasmal 10% Solution for Infusion. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.